The Effect of Acupressure and Reiki on Pain and Fatigue Levels

Sponsor
Mardin Artuklu University (Other)
Overall Status
Completed
CT.gov ID
NCT05473845
Collaborator
(none)
156
1
3
5.3
29.7

Study Details

Study Description

Brief Summary

This research was conducted with the aim of determining the effect of levels of pain and fatigue of acupressure and Reiki application on cancer patients receiving palliative care. The research was a single-blind, repeated measures, randomized controlled study. Research data were collected between February and July 2022. The research sample consisted of acupressure and Reiki application groups and a control group with 52 patients in each group, a total of 156 patients. Data was collected by means of a Patient Description Form, an Analgesic Follow-up Form, the Eastern Cooperative Oncology Group Performance Status Scale, the Numeric Pain Rating Scale, and the Brief Fatigue Inventory.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Acupressure intervention
  • Procedure: Reiki intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
156 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Acupressure and Reiki on Pain and Fatigue Levels in Cancer Patients Receiving Palliative Care
Actual Study Start Date :
Feb 11, 2022
Actual Primary Completion Date :
Jul 21, 2022
Actual Study Completion Date :
Jul 21, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acupressure

Acupressure intervention

Procedure: Acupressure intervention
Acupressure

Experimental: Reiki

Reiki intervention

Procedure: Reiki intervention
Reiki

No Intervention: Control

No intervention.

Outcome Measures

Primary Outcome Measures

  1. Numeric Pain Rating Scale [on the second day of the starting week]

    A score of 0 indicates no pain, 1-3 slight pain, 4-6 moderate pain, and 7-10 severe pain .

  2. Brief Fatigue Inventory [on the second day of the starting week]

    It is scored between 0 and 10.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. having a diagnosis of third or fourth-stage cancer,

  2. being aged 18 years or older,

  3. having had pain for at least one month in connection with cancer treatment or the symptoms of the disease,

  4. using NSAII or non-opioid analgesics,

  5. having a status of 3 or more on the Numeric Pain Rating Scale (NPRS),

  6. having a score of 0-3 on the ECOG-PS scale

Exclusion Criteria:
  1. having a diagnosis of first or second-stage cancer,

  2. being aged less than 18 years,

  3. having bone or brain metastasis,

  4. using opioid analgesics,

  5. having a status of less than 3 on the NPRS,

  6. having a status of between 4 and 5 on the ECOG-PS scale

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hediye Utli Mardin Turkey 47200

Sponsors and Collaborators

  • Mardin Artuklu University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
HEDİYE UTLİ, PhD, MSc, RN, Assistant Professor, Mardin Artuklu University
ClinicalTrials.gov Identifier:
NCT05473845
Other Study ID Numbers:
  • HUTLİ
First Posted:
Jul 26, 2022
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022